BSE filing, NSE: GSFC. Summary written from the filing by ALFA Finder's alert engine.
Gujarat State Fertilizer & Chemicals Ltd: key numbers
- Share price
- ₹136.41
- Market cap
- ₹5,436 Cr
- Revenue (annual)
- ₹10,946 Cr
- Net profit (annual)
- ₹672.8 Cr
- P/E (TTM)
- 7.8×Sector 9.6×
- Promoter holding
- 37.84%+0.00% QoQ
- FII holding
- 12.51%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat State Fertilizer & Chemicals Ltd
All →Gujarat State Fertilizer & Chemicals Capacity Expansion
Gujarat State Fertilizers & Chemicals approved setting up a new Phosphoric Acid and Sulphuric Acid plant at its Sikka Unit for backward integration.
- manufacturing capacity
- 2400.0 MTPD
Gujarat State Fertilizer & Chemicals Board Meeting Date
Gujarat State Fertilizers & Chemicals Ltd has scheduled a board meeting for 2nd November, 2026, to consider and approve its unaudited financial results.
Gujarat State Fertilizer & Chemicals Other Announcement
Gujarat State Fertilizers & Chemicals Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required under SEBI regulations.
Gujarat State Fertilizer & Chemicals Credit Rating
CARE Ratings reaffirmed GSFC's credit ratings for bank facilities and Commercial Papers. Long-term bank facilities carry a CARE AA+ rating with a stable outlook.
Gujarat State Fertilizer & Chemicals Board Meeting Date
Gujarat State Fertilizers & Chemicals Ltd will hold a Board Meeting on October 12, 2026, to consider and approve the financial results for the quarter ended September 2026.
Gujarat State Fertilizer & Chemicals Annual General Meeting
Gujarat State Fertilizers & Chemicals Ltd held its 64th Annual General Meeting on September 28, 2026, to discuss financial statements, dividend declaration, and director re-appointments.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.